Filing Details
- Accession Number:
- 0001209191-22-034036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-03 16:18:29
- Reporting Period:
- 2022-06-01
- Accepted Time:
- 2022-06-03 16:18:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1217456 | Stewart H Parker | C/O Sangamo Therapeutics, Inc. 7000 Marina Blvd. Brisbane CA 94005 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-01 | 5,000 | $3.60 | 48,700 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
